French pharma giant Sanofi said Tuesday that international Phase 3 clinical tests of its Kevzara drug for serious Covid-19 cases had proved inconclusive and it was halting the trial. The Phase 3 test – normally the last before official approval for use – “did not meet the primary or secondary evaluation criteria compared with a […]